Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 11 studies | 74% ± 25% | |
GABAergic neuron | 10 studies | 55% ± 23% | |
microglial cell | 7 studies | 28% ± 18% | |
neuron | 6 studies | 34% ± 17% | |
interneuron | 6 studies | 47% ± 30% | |
oligodendrocyte precursor cell | 5 studies | 21% ± 5% | |
endothelial cell | 5 studies | 38% ± 17% | |
B cell | 5 studies | 30% ± 14% | |
astrocyte | 4 studies | 35% ± 26% | |
natural killer cell | 4 studies | 30% ± 5% | |
GABAergic interneuron | 3 studies | 67% ± 7% | |
oligodendrocyte | 3 studies | 41% ± 24% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 13 studies | 45% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 92% | 599.96 | 599 / 653 | 83% | 4.42 | 503 / 605 |
brain | 69% | 2101.43 | 1812 / 2642 | 89% | 8.38 | 628 / 705 |
muscle | 100% | 3452.53 | 800 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 15.13 | 79 / 80 |
lymph node | 0% | 0 | 0 / 0 | 79% | 2.74 | 23 / 29 |
skin | 7% | 24.68 | 133 / 1809 | 69% | 4.94 | 326 / 472 |
blood vessel | 73% | 343.83 | 981 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 7% | 28.57 | 17 / 258 | 64% | 8.93 | 147 / 230 |
prostate | 43% | 128.24 | 106 / 245 | 26% | 0.44 | 131 / 502 |
bladder | 52% | 214.24 | 11 / 21 | 12% | 0.47 | 62 / 504 |
esophagus | 21% | 60.14 | 306 / 1445 | 39% | 1.62 | 71 / 183 |
spleen | 57% | 161.99 | 138 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 56% | 1.97 | 25 / 45 |
lung | 1% | 2.28 | 6 / 578 | 52% | 2.19 | 601 / 1155 |
breast | 3% | 7.52 | 12 / 459 | 41% | 1.93 | 461 / 1118 |
intestine | 23% | 72.93 | 221 / 966 | 4% | 0.09 | 21 / 527 |
ovary | 1% | 2.43 | 2 / 180 | 26% | 0.92 | 110 / 430 |
peripheral blood | 24% | 526.25 | 222 / 929 | 0% | 0 | 0 / 0 |
uterus | 2% | 7.05 | 3 / 170 | 22% | 0.70 | 101 / 459 |
stomach | 11% | 35.10 | 39 / 359 | 5% | 0.17 | 14 / 286 |
pancreas | 0% | 0 | 0 / 328 | 11% | 0.27 | 20 / 178 |
kidney | 0% | 0 | 0 / 89 | 7% | 0.17 | 67 / 901 |
liver | 0% | 0 | 0 / 226 | 2% | 0.06 | 9 / 406 |
heart | 1% | 1.98 | 7 / 861 | 0% | 0 | 0 / 0 |
adipose | 0% | 0.15 | 1 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071805 | Biological process | potassium ion transmembrane transport |
GO_0030118 | Cellular component | clathrin coat |
GO_0005886 | Cellular component | plasma membrane |
GO_0008076 | Cellular component | voltage-gated potassium channel complex |
GO_0005249 | Molecular function | voltage-gated potassium channel activity |
GO_0005515 | Molecular function | protein binding |
Gene name | KCNQ5 |
Protein name | Potassium voltage-gated channel subfamily Q member 5 Potassium voltage-gated channel subfamily KQT member 5 (KQT-like 5) (Potassium channel subunit alpha KvLQT5) (Voltage-gated potassium channel subunit Kv7.5) |
Synonyms | |
Description | FUNCTION: Associates with KCNQ3 to form a potassium channel which contributes to M-type current, a slowly activating and deactivating potassium conductance which plays a critical role in determining the subthreshold electrical excitability of neurons. Therefore, it is important in the regulation of neuronal excitability. May contribute, with other potassium channels, to the molecular diversity of a heterogeneous population of M-channels, varying in kinetic and pharmacological properties, which underlie this physiologically important current. Insensitive to tetraethylammonium, but inhibited by barium, linopirdine and XE991. Activated by niflumic acid and the anticonvulsant retigabine. As the native M-channel, the potassium channel composed of KCNQ3 and KCNQ5 is also suppressed by activation of the muscarinic acetylcholine receptor CHRM1. . |
Accessions | H0Y3Z0 A6PVT8 ENST00000628967.2 [Q9NR82-5] ENST00000342056.6 [Q9NR82-6] A6PVT7 ENST00000629977.2 [Q9NR82-2] F8WEA4 ENST00000355194.9 ENST00000427928.1 ENST00000370398.6 [Q9NR82-1] ENST00000441538.1 ENST00000370392.5 [Q9NR82-4] Q9NR82 ENST00000443915.1 |